On Tuesday shares of Key Energy Services Inc. (NYSE:KEG) closed at $2.00. Company’s sales growth for last 5 years was 8.40% and EPS growth for next 5 years is recorded as -11.43%. Key Energy Services Inc. (NYSE:KEG) said that, it will report first quarter 2015 financial results after market close on Wednesday, April 29, 2015, and Key management will host a conference call to discuss these results on Thursday, April 30, 2015 at 10:00 a.m. CDT.
Visa Inc. (NYSE:V) in last trading activity moved down -0.12% to close at $65.53. Company weekly performance is -0.41% while its quarterly performance stands at 0.99%. Visa Inc. (NYSE:V) is -5.93% away from its 52 week high. Visa Inc. (NYSE:V) said that, it will report its fiscal second quarter 2015 financial results on Thursday, April 30, 2015.
On last trading day Sony Corp (ADR) (NYSE:SNE) moved up 2.50% to close at $31.13. Its volatility for the week is 1.23% while volatility for the month is 1.28%. SNE’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was -4.90%. Sony Corp (ADR) (NYSE:SNE) monthly performance is 17.21%. On 7 April, Sony Corp (ADR) (NYSE:SNE) said it would spend an extra 45 billion yen ($376 million) in the fiscal year that started this month to further boost output of imaging sensors, increasing its focus on a business that has become one of its strongest as its TV and mobile operations struggle.
Universal Truckload Services Inc. (NASDAQ:UACL) has 0.20% insider ownership while its institutional ownership stands at 27.40%. In last trading activity company’s stock closed at $21.39. Stifel Nicolaus downgraded its rating on shares of Universal Truckload Services Inc. (NASDAQ:UACL) to “Hold” from “Buy.”
Neostem, Inc. (NASDAQ:NBS) in last trading activity remains unchanged to close at $2.96. Company weekly performance is -3.90% while its quarterly performance stands at -27.09%. Neostem, Inc. (NASDAQ:NBS) is -59.06% away from its 52 week high. On 9 April, Neostem, Inc. (NASDAQ:NBS) announced the extension of its study under a 2014 Early Translational grant from the California Institute of Regenerative Medicine for research leading to the development of a treatment for retinal diseases, including macular degeneration and retinitis pigmentosa.